应用全血细胞计数组分筛查新生儿遗传性球形红细胞增多症
本研究在1995至2015年间纳入15家Kaiser Permanente北加州医院出生的≥35周婴儿共670 272例,评估新生儿HS指数(MCHC/MCV)筛查遗传性球形红细胞增多症的效用。HS确诊79例(1.2/10 000),HS指数ROC曲线下面积0.84(95%CI 0.78-0.90);以0.36为界,敏感性56%、特异性93%。结论认为该指数区分HS的能力有限。
要点
- HS指数(MCHC/MCV)在出生一周内CBC中区分HS的能力仅为中等,AUC 0.84。
- 以0.36为界,HS指数敏感性56%、特异性93%,似然比范围10.1至0.1。
- HS指数在总胆红素<10 mg/dL的婴儿中区分度似乎最佳。
核心结论
- 出生一周内CBC获得的HS指数改变HS概率的能力仅为中等。
研究设计与样本
- 回顾性队列研究纳入1995至2015年15家Kaiser Permanente北加州医院出生、胎龄≥35周的婴儿共670 272例。
- 获取出生≤7天首次CBC的红细胞指数及≤30天总胆红素水平,HS诊断经病历审查确认。
主要发现
- 79例婴儿确诊HS,发生率为1.2/10 000。
- HS在白人和「其他」种族或族裔婴儿中及峰值总胆红素较高者中更常见。
- HS指数的ROC曲线下面积为0.84(95%CI 0.78-0.90)。
- 似然比从HS指数≥0.380的10.1到HS指数<0.310的0.1。
- 以0.36二分时,HS指数敏感性56%、特异性93%。
关键数值与推荐
- HS指数定义为平均红细胞血红蛋白浓度除以平均红细胞体积。
- HS指数>0.36在主要为白人婴儿的人群中敏感性97%、特异性>99%(原文背景引用)。
- 本研究中以0.36为界,敏感性56%、特异性93%。
- HS指数在总胆红素<10 mg/dL的婴儿中区分度似乎最佳。
临床怎么用
- 新生儿HS指数可用于筛查参考,但区分能力有限,不能单独作为确诊依据。
- 对于总胆红素<10 mg/dL的婴儿,HS指数的区分度似乎更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The neonatal hereditary spherocytosis (HS) index, defined as the mean corpuscular hemoglobin concentration divided by the mean corpuscular volume, has been proposed as a screening tool for HS in neonates. In a population of mostly white infants, an HS Index >0.36 was 97% sensitive and >99% specific. We evaluated the utility of the HS Index among a more racially and ethnically diverse population and determined if its discrimination varies with total serum bilirubin (TSB) levels. METHODS: Infants born at ≥35 weeks' gestation at 15 Kaiser Permanente Northern California hospitals from 1995 to 2015 were eligible (N = 670 272). Erythrocyte indices from the first complete blood count drawn at ≤7 days and TSB levels drawn at ≤30 days were obtained. Diagnoses of HS were confirmed via chart review. RESULTS: HS was confirmed in 79 infants, 1.2 per 10 000. HS was more common among infants of white and "other" race or ethnicity and among those with higher peak TSB levels. The area under the receiver operating characteristic curve for the HS Index was 0.84 (95% confidence interval 0.78-0.90). Likelihood ratios ranged from 10.1 for an HS Index ≥0.380 to 0.1 for an HS Index <0.310. Dichotomized at 0.36, the HS Index was 56% sensitive and 93% specific. Discrimination of the HS Index appeared best among infants with TSB levels <10 mg/dL. CONCLUSIONS: The HS Index, when obtained from a CBC drawn within the first week after birth, had only modest ability to alter the probability of HS.
引用
- Weiss NM, Kuzniewicz MW, Shimano KA, et al. Use of Complete Blood Cell Count Components to Screen for Hereditary Spherocytosis in Neonates. Pediatrics. 2021. PMID: 34376530. doi:10.1542/peds.2020-021642
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。